Global Self-Testing Market, by Product Type  (Kits (Self-testing kits, Self-collection kits) Self-testing Devices), by Application Type (Blood Glucose Testing, Pregnancy Testing, Pulmonary Function Testing, Urinary Tract Infection Testing, Sexually transmitted infections (STIs) Testing, Genetic Testing, Vitamin and Mineral Deficiency Testing, COVID Testing, Allergy Testing, Gastrointestinal Screening, Hormone Testing, Food Sensitivity Testing, Others (Infectious Disease Testing, etc.)), by Sample Type (Blood, Saliva, Nasal, Stool, Urine and Others (Vaginal Swab Sample and Breathe Sample)), by Test Type (Laboratory Tests, Point of Care Tests/Homecare Tests), by Distribution Channel (Offline (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Supermarkets and Hypermarket) and Online), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) is estimated to be valued at US$  20,117.5 Million in 2022 and projected to exhibit a CAGR of 8.7 % during the forecast period (2022-2030).

The increasing prevalence of chronic diseases such as diabetes and HIV (Human immunodeficiency virus infection) is expected to augment the global self-testing market growth over the forecast period.

According to the United Nations Program on HIV and AIDS (UNAIDS) global report 2021, there were approximately 38.4 million HIV-positive people worldwide. Out of which 36.7 million were adults (15 years or older) and 1.7 million were children (0–14 years). In addition, 54% of all people living with HIV were women and girls.

Moreover, 85% of all people living with HIV knew their HIV status and about 5.9 million people globally did not know that they were living with HIV in 2021. The number of people died from AIDS-related illnesses in 2021 was estimated to be 650 000.

Hence, HIV testing is a critical entry point for HIV prevention, treatment, care, and support services.

Global Self-Testing Market – Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic has affected various industries globally. Key players operating in the global self-testing market are facing major challenges on various fronts due to the COVID-19 pandemic. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally, as of 18 August 2022, are approximately 590,659,276 confirmed cases with 6,440,163 deaths.

The COVID-19 pandemic has affected the economy in three main ways: by directly affecting the production and demand; by creating disruptions in distribution channels; through its financial impact on firms and financial markets.

Several government authorities and non-profit organizations are involved in investments and funding for COVID-19 self-testing kits. Moreover, the increasing number of product launches and approvals related to COVID-19 self-test kits is expected to positively impact the global self-testing market growth over the forecast period.

One of the biggest challenges due to the COVID-19 pandemic is limited supply of raw materials required to manufacture biopharmaceuticals and other reagents due to irregularities in the transportation system.

Browse 52 Market Data Tables and 50 Figures spread through 197 Pages and in-depth TOC on “Global Self-Testing Market ” - Forecast to 2030, Global Self-Testing Market, by Product Type  (Kits (Self-testing kits, Self-collection kits) Self-testing Devices), by Application Type (Blood Glucose Testing, Pregnancy Testing, Pulmonary Function Testing, Urinary Tract Infection Testing, Sexually transmitted infections (STIs) Testing, Genetic Testing, Vitamin and Mineral Deficiency Testing, COVID Testing, Allergy Testing, Gastrointestinal Screening, Hormone Testing, Food Sensitivity Testing, Others (Infectious Disease Testing, etc.)), by Sample Type (Blood, Saliva, Nasal, Stool, Urine and Others (Vaginal Swab Sample and Breathe Sample)), by Test Type (Laboratory Tests, Point of Care Tests/Homecare Tests), by Distribution Channel (Offline (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Supermarkets and Hypermarket) and Online) and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Forecast to 2030

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/self-testing-market-4902

Key Takeaways of the Global Self-Testing Market:

  • The global self-testing market is expected to exhibit a CAGR of 8.7 during the forecast period, owing to the increasing launch of new products. For instance, in December 2021, OmegaQuant, a leader in nutrient status testing, launched a new vitamin B12 test that includes a sample collection kit for at-home testing. The test measures a substance called methylmalonic acid (MMA) in the urine to accurately detect low B12 status. The more MMA a person has, the more likely he or she has low B12.
  • Based on product type, the kits segment is estimated to account for the largest market share in the global self-testing market in 2022. Increasing product launches by market players and their regulatory approvals are expected to drive the segment growth over the forecast period. For instance, according to article published by the Economic Times, on 13 June 2022, Genes2Me Pvt. Ltd., one of the leading companies in the Molecular Diagnostics space in India announced the launch of its CoviEasy Self-Test Rapid Antigen test kit for COVID-19.

Major players operating in the global self-testing market include Becton, Dickinson and Company, Abbott, ACCESS BIO, CELLTRION INC., Siemens Healthcare GmbH, ACON Laboratories Inc., ARKRAY, Inc, F.Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Btnx Inc., iHealth Labs Inc., InBios International, Inc. USA. And True Diagnostics Inc.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo